Biomet, Inc. v. Smith

238 F. Supp. 2d 1036, 2002 U.S. Dist. LEXIS 25026, 2002 WL 31931606
CourtDistrict Court, N.D. Indiana
DecidedDecember 23, 2002
DocketCause 3:01CV0753 AS
StatusPublished
Cited by2 cases

This text of 238 F. Supp. 2d 1036 (Biomet, Inc. v. Smith) is published on Counsel Stack Legal Research, covering District Court, N.D. Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Biomet, Inc. v. Smith, 238 F. Supp. 2d 1036, 2002 U.S. Dist. LEXIS 25026, 2002 WL 31931606 (N.D. Ind. 2002).

Opinion

MEMORANDUM AND ORDER

ALLEN SHARP, Judge.

This cause is before the Court on Biom-et’s Motion for Summary Judgment filed on September 3, 2002, and Biomet’s Motion to Strike filed on October 15, 2002. The case arises out the circumstances surrounding Biomet’s termination of Wayne Smith as its sole distributor for a sales region in Texas. The parties have briefed the issues and filed the appropriate responses and replies, and the Motions are ripe for ruling. The Court has considered the submissions of the parties and the voluminous record in this case and now rules as follows.

7. JURISDICTION

Jurisdiction is premised upon complete diversity of citizenship pursuant to 28 U.S.C. § 1332(a), and an amount in controversy in excess-of $75,000.00.

II. RELEVANT FACTS

Biomet is a manufacturer of orthopedic implants and related instrumentation. Biomet’s Mem. in Supp. at 2. Biomet distributes its products through a network of authorized, independent sales representatives. Id. The Defendant, Counter-Plaintiff, Wayne Smith, was a distributor for Kirschner Medical Corporation, a medical products company in South Texas, beginning in 1988. Biomet’s Mem. in Supp. at 2; Smith’s Mem. in Opp. at 2. Kirschner Medical Corporation was acquired by Biomet in 1994. Id. As a distributor for Kirschner, Smith had a sales staff and an existing client base in South Texas. Id.

After Biomet acquired Kirschner, it entered into an agreement with Smith under which he would be the sales representative for Biomet products covering the same territory. Id. This agreement was memorialized in a letter dated October 14, 1994 (the letter agreement). Smith’s Answer, Ex. 1. The letter stated, “It is agreed and understood that either of us may terminate this relationship, with or without cause, by giving the other thirty (30) days’ written notice of such termination.” Id., at page 2. Other relevant portions of the agreement state that as a distributor for Biomet, Smith was expected “to operate in accordance with all Biomet distributor policies and procedures,” (Ex. 1 at ¶ a); “to maintain a competent and aggressive salesforce to market and sell Biomet Products,” (Id. at ¶ b); to equal or exceed the sales quotas and percentage increases established by Biomet for his territory every year, (Id. at ¶ c); to devote his full business time, attention and best efforts in marketing, promoting and selling Biomet Products; and not to engage in any business that competes directly or indirectly with the sale of Biomet Products, (Id. at ¶ d).

The agreement contained a covenant not to compete, but it only applied in the event that Smith terminated the relationship. Id. at 2-3. The agreement also stated that “in the event of any dispute between us, *1040 the laws of the State of Indiana shall govern the validity, performance, interpretation, enforcement and any other aspect of our agreement or relationship.” Id., at 3.

In order to market and sell Biomet’s products in the territory, Smith contracted with three sales associates. Smith’s Mem. in Opp. at 2. Sales agents are often present during surgical procedures when their products are being used to ensure that all necessary supplies and instrumentation are available and to provide technical assistance to the surgeons. Id. Therefore, success in marketing Biomet’s products requires that the sales agents have medical knowledge and technical expertise, as well as the ability to develop strong working relationships with doctors and hospital personnel. Id.

In addition, Biomet distributors are required to purchase and maintain the instruments used by surgeons to implant Biomet devices. Id. at 20. Smith purchased in excess of four hundred thousand dollars ($400,000.00) worth of instruments with a retail value of in excess of one million dollars ($1,000,000.00). In 1997, Biomet issued a new Biomet Distributor Policy Manual which states that Biomet is under no obligation to repurchase instrumentation from retiring or terminated distributors.

On April 21, 2001, the parties amended the letter agreement to include an additional county in Smith’s territory. Id., at 6. Then, on July 10, 2001, Biomet’s Southwest Area Vice President, Terry Geurink, informed Smith that Biomet was terminating its business relationship with him as of July 10, 2001. A letter was hand delivered to Smith the same day to confirm the termination. Smith’s Ans., Ex. 2. The letter stated that Biomet would continue to pay Smith commissions on all orders placed with Biomet for the next thirty days, but that he was relieved of all responsibilities effective immediately. Id. The reason given for the termination was the fact that Smith failed to achieve a satisfactory level of sales growth when compared to Biomet’s domestic sales growth, and includes a chart comparing Smith’s sales growth with Biomet’s. Id. at page 2.

Before informing Smith that he was being terminated, Biomet made arrangements to have two sales representatives take over his territory. Id. at 3. Within hours after delivering the termination letter to Smith, a representative from Biomet called Smith’s sales agents to inform them that Smith was terminated and to ask them to continue selling Biomet products. Id. Two of Smith’s sales agents agreed to work with the new distributors and continue selling Biomet products, effective immediately. These two agents and their clients accounted for a substantial portion of Smith’s business, according to figures provided by Biomet. Biomet’s Mem. in Supp. at 2 and 5. A single doctor, Dr. Bassett, represented nearly 65% of Smith’s business, and he agreed to continue using Biomet products. 1 Id.

After receiving the termination letter, Smith was able to contact one of his agents, Anna Rose Arsenian, before Biom-et contacted her. Smith Mem. in Opp. at 24. She declined to become a Biomet sales agent, and the doctor she represented said he was no longer interested in using Biom-et products. Id. at 6. Biomet claims that their representatives did not speak with this agent at all, but Smith has provided deposition testimony from Geurink and an Affidavit from the sales agent stating that Geurink and another Biomet representa *1041 tive met with her and asked her to continue representing Biomet. See, Biomet Mem. in Supp. at 6; but see, Geurink Deposition at p. 56, lines 20-24; Arsenian Aff. Smith’s Ex. 22. Smith had written contracts with two of his three agents requiring them to give thirty day notice to Smith to terminate the agreements. Id. One of the agents that quit immediately to work for Biomet’s new distributors was under contract with Smith. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Smith v. Biomet, Inc.
384 F. Supp. 2d 1241 (N.D. Indiana, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
238 F. Supp. 2d 1036, 2002 U.S. Dist. LEXIS 25026, 2002 WL 31931606, Counsel Stack Legal Research, https://law.counselstack.com/opinion/biomet-inc-v-smith-innd-2002.